🇺🇸 FDA
Patent

US 8227443

Silencing of CSN5 gene expression using interfering RNA

granted A61KA61K48/00A61P

Quick answer

US patent 8227443 (Silencing of CSN5 gene expression using interfering RNA) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K48/00, A61P, A61P35/00